Therapy directed toward activating the Nrf2–ARE pathway, such as the use of astaxanthin, may be a novel preventive and therapeutic strategy for attenuating oxidative stress in the pathogenesis of COPD. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.